video of injecting tirzepatide How to inject with a syringe: complete step-by-step guide Close-up view of a hand

Depending on the formula, both semaglutide and tirzepatide medications are FDA-approved for either weight loss or type 2 diabetes treatment

Possible Side Effects Observed in Research Settings Because Tirzepatide interacts with GLP-1 and GIP receptor pathways involved in appetite regulation, glucose signaling, digestion, and metabolic function, observed responses in research settings are commonly gastrointestinal and metabolic in nature

It is not recommended during pregnancy or breastfeeding

SURMOUNT-1 extensin 3 aos

Discuss formulation specifics: Ask your provider and the pharmacy what specific form of the active ingredient is used (e.g., semaglutide base vs semaglutide sodium salt), as this can affect dosing and conversion from branded product dosing

Tirzepatide targets both GLP-1 and GIP, whereas semaglutide only targets GLP-1